The World Health Organization Prequalification Team (PQT) - Medicines in collaboration with the CCCMHPIE, will be attending the Shanghai SNIEC CPhi on 21-23 June 2016, in Shanghai, China.
For most international procurement agencies, WHO prequalification or stringent regulatory approval is a prerequisite when applying for medicine tender contracts. WHO-prequalified finished pharmaceutical products (FPPs) and active pharmaceutical ingredients (APIs) are publicly listed and recognized as meeting international quality and good manufacturing practice requirements. Increasingly, the prequalification status of an FPP and API is accepted by national regulatory authorities in Africa and leads to faster registration.
The focus of the WHO Prequalification Team – Medicines (PQT-Medicines) is medicines and APIs needed for treating high-burden diseases such as HIV/AIDS, hepatitis C, malaria, tuberculosis, and neglected tropical diseases - and for reproductive health. Complete list of APIs and FPPs invited for prequalification can be viewed at: /prequal/sites/default/files/documents/FPPs_APIs_invited_0.xlsx
PQT Medicines, in collaboration with the CCCMHPIE, will attend the Shanghai SNIEC CPhi on 21‒23 June 2016, China. PQT Medicines staff will be available at the CCCMHPIE booth (E3P06) on the 21 June (09:00-17:00) and 22 -23 June (09:00-12:00) to answer questions regarding FPP and API prequalification procedures.
Companies who would like to arrange a face-to-face meeting for either of those days should email:
- Dr Antony Fake at fakea@who.int, cc Dr Matthias Stahl at stahlm@who.int
In addition, on 22 June, PQT Medicines staff will present on WHO prequalification procedures followed by discussions and further opportunities for one-on-one discussions until 17:00.
Further information on the CCCPHPIE booth number and presentation topics will be posted soon.
This notice is primarily posted to allow requests for face to face meetings.
For further information please contact Dr Antony Fake at: fakea@who.int